Ab interno stenting procedures

Nathan M. Radcliffe; Mary G. Lynch; Reay H. Brown

doi:10.1016/j.jcrs.2014.01.033

Ab interno stenting procedures

Nathan M. Radcliffe, Mary G. Lynch, Reay H. Brown

Research output: Contribution to journal › Article › peer-review

5 Scopus citations

Abstract

Trabecular bypass was first used as a surgical treatment for glaucoma more than 100 years ago and aims to circumvent the trabecular meshwork, thought to be the main site of aqueous humor outflow resistance. The emerging field of microinvasive glaucoma surgery has brought a new ab interno trabecular microbypass stent through the U.S. Food and Drug Administration-approval process, and data from long-term randomized prospective trials have shown the safety and intraocular pressure-lowering value of trabecular microbypass. This review discusses the historical evolution of trabecular microbypass and describes new and forthcoming surgical options along with available clinical safety and efficacy data. Financial Disclosure Proprietary or commercial disclosures are listed after the references.

Original language	English
Pages (from-to)	1273-1280
Number of pages	8
Journal	Journal of Cataract and Refractive Surgery
Volume	40
Issue number	8
DOIs	https://doi.org/10.1016/j.jcrs.2014.01.033
State	Published - Aug 2014
Externally published	Yes

Access to Document

10.1016/j.jcrs.2014.01.033

Cite this

@article{c6d63242536a454cb5bdd0848ef1a82c,

title = "Ab interno stenting procedures",

abstract = "Trabecular bypass was first used as a surgical treatment for glaucoma more than 100 years ago and aims to circumvent the trabecular meshwork, thought to be the main site of aqueous humor outflow resistance. The emerging field of microinvasive glaucoma surgery has brought a new ab interno trabecular microbypass stent through the U.S. Food and Drug Administration-approval process, and data from long-term randomized prospective trials have shown the safety and intraocular pressure-lowering value of trabecular microbypass. This review discusses the historical evolution of trabecular microbypass and describes new and forthcoming surgical options along with available clinical safety and efficacy data. Financial Disclosure Proprietary or commercial disclosures are listed after the references.",

author = "Radcliffe, {Nathan M.} and Lynch, {Mary G.} and Brown, {Reay H.}",

year = "2014",

month = aug,

doi = "10.1016/j.jcrs.2014.01.033",

language = "English",

volume = "40",

pages = "1273--1280",

journal = "Journal of Cataract and Refractive Surgery",

issn = "0886-3350",

publisher = "Wolters Kluwer Health",

number = "8",

}

TY - JOUR

T1 - Ab interno stenting procedures

AU - Radcliffe, Nathan M.

AU - Lynch, Mary G.

AU - Brown, Reay H.

PY - 2014/8

Y1 - 2014/8

N2 - Trabecular bypass was first used as a surgical treatment for glaucoma more than 100 years ago and aims to circumvent the trabecular meshwork, thought to be the main site of aqueous humor outflow resistance. The emerging field of microinvasive glaucoma surgery has brought a new ab interno trabecular microbypass stent through the U.S. Food and Drug Administration-approval process, and data from long-term randomized prospective trials have shown the safety and intraocular pressure-lowering value of trabecular microbypass. This review discusses the historical evolution of trabecular microbypass and describes new and forthcoming surgical options along with available clinical safety and efficacy data. Financial Disclosure Proprietary or commercial disclosures are listed after the references.

AB - Trabecular bypass was first used as a surgical treatment for glaucoma more than 100 years ago and aims to circumvent the trabecular meshwork, thought to be the main site of aqueous humor outflow resistance. The emerging field of microinvasive glaucoma surgery has brought a new ab interno trabecular microbypass stent through the U.S. Food and Drug Administration-approval process, and data from long-term randomized prospective trials have shown the safety and intraocular pressure-lowering value of trabecular microbypass. This review discusses the historical evolution of trabecular microbypass and describes new and forthcoming surgical options along with available clinical safety and efficacy data. Financial Disclosure Proprietary or commercial disclosures are listed after the references.

UR - http://www.scopus.com/inward/record.url?scp=84905459835&partnerID=8YFLogxK

U2 - 10.1016/j.jcrs.2014.01.033

DO - 10.1016/j.jcrs.2014.01.033

M3 - Article

C2 - 25088624

AN - SCOPUS:84905459835

SN - 0886-3350

VL - 40

SP - 1273

EP - 1280

JO - Journal of Cataract and Refractive Surgery

JF - Journal of Cataract and Refractive Surgery

IS - 8

ER -

Ab interno stenting procedures

Abstract

Access to Document

Fingerprint

Cite this